Peritonitis in Latin America

Peritoneal Dialysis International

Volumn 27, Issue 3, 2007, Pages 332-339

  Barretti, Pasqual ^a   Bastos, Kleyton A ^b   Dominguez, Jorge ^c   Caramori, Jacqueline C T ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^c Miguel Perez Carreño Hospital   (Venezuela)

Author keywords

Latin America; Peritonitis

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; CEFALOTIN; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEPHALOSPORIN; GENTAMICIN; IMIPENEM; METICILLIN; OFLOXACIN; OXACILLIN; PSEUDOMONIC ACID; TOBRAMYCIN; VANCOMYCIN;

AGE DISTRIBUTION; ANTIBIOTIC RESISTANCE; BACTERIAL STRAIN; CLIMATE CHANGE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DIABETES MELLITUS; DISEASE CARRIER; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GEOGRAPHIC DISTRIBUTION; HEALTH CARE AVAILABILITY; HEMODIALYSIS; HUMAN; INCIDENCE; KLEBSIELLA; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; PATHOGENESIS; PERITONEAL DIALYSIS; PERITONITIS; PREVALENCE; PRIORITY JOURNAL; PSEUDOMONAS; RACE DIFFERENCE; REVIEW; RISK FACTOR; SOCIAL STATUS; SOUTH AND CENTRAL AMERICA; SPECIES DIFFERENCE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 34447311070     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080702700324     Document Type: Review

References (70)

1. Cusumano A, Garcia GG, Di Gioia C, Hermida O, Lavorato C. The Latin American Dialysis and Transplantation Registry (RLDT) annual report 2004. Ethn Dis 2006; 6(Suppl 2): S10-13.
2. Riella MC, Marcos E, Cato J. Diálise peritoneal contínua ambulatorial (CAPD): experiência de 5 anos. Rev Assoc Med Bras 1987; 33:15-20.
3. D'Avila DO, Von Eye O, Santos CA, Lerner L, Antonello I, Oliveira RM, et al. Diálise peritoneal ambulatorial contínua: experiência de um centro universitário. Revista da AMRIGS 1987; 31(1):7-13.
4. Bevilacqua JL. Brazilian multicenter study - peritonitis dueto S. aureus. Presented at the Vth Congress of the International Society for Peritoneal Dialysis, Kyoto, Japan, 1990.
5. Monteon D, Correa-Rotter R, Paniagua R, Amato D, Hurtado ME, Medina JL, et al. Prevention of peritonitis with disconnect systems in CAPD: a randomized controlled trial. The Mexican Nephrology Collaborative Study Group. Kidney Int 1998; 54:2123-8.
6. Bevilacqua JL, Marabezi MGB, Caniello CA, Camargo MC, Neves AV, Gomes JG. Diálise peritoneal contínua ambulatorial (DPAC): experiência de 10 anos de um centro brasileiro. Jornal Brasileiro Nefrologia 1995; 17:206-13.
7. Gonçalves EAP, Sardenberg LC, Ikeda MAJ, Nadaletto SA, Draibe SA, Cendorologlo M. Jornal Brasileiro Nefrologia 1998; XX:165-P389.
8. Figueiredo AE, Poli de Figueiredo CE, d'Avila DO. Bag exchange in continuous ambulatory peritoneal dialysis without use of a face mask: experience of five years. Adv Perit Dial 2001; 17:98-100.
9. Figueiredo AE, Poli de Figueiredo CE, D'Avila DO. Peritonitis prevention in CAPD: to mask or not? Perit Dial Int 2000; 20:354-8.
10. Caramori JCT. Peritonites em pacientes tratados com diálise peritoneal ambulatorial contínua: estudo clínico e microbiológico [Tese doutoramento]. Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, São Paulo, Brazil; 1999.
11. Pereira ERPC, Gabriel DP, Lorençon M, Cruz AP. Análise retrospectiva de 92 episódios de peritonite em pacientes tratados pordiálise peritoneal. Jornal Brasileiro Nefrologia 2004; XXVI:109-P241.
12. Kavanagh D, Prescott JG, Mactier RA, on behalf of the Scottish Renal Registry. Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 2004; 19:2584-91.
13. Mujais S. Microbiology and outcomes of peritonitis in North America. Kidney Int Suppl 2006; 103:S55-62.
14. Dasgupta MK, Fox S, Gagnon D, Bettcher K, Ulan RA. Significant reduction of peritonitis rate by the use of twin-bag system in a Canadian regional CAPD program. Adv Perit Dial 1992; 8:223-6.
15. Concha S. Diálisis peritoneal ambulatoria continua: diez años de experiencia en un centro de tratarniento. Acta Médica Colombiana 1994; 19:340-50.
16. Tielens E, Nube MJ, de Vet JA, van Limbeek J, Hofman X, Steffens A, et al. Major reduction of CAPD peritonitis after the introduction of the twin-bag system. Nephrol Dial Transplant 1993; 8:1237-43.
17. Bernardini J, Bender F, Florio T, Sloand J, PalmMontalbano L, Fried L, et al. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005; 16: 539-45.
18. Moreira PRR, Ferreira S, Almas ACG, Peralva LEL, Brega AP. Mupirocina tópica no orifício de saída do cateter reduz infecçãdo decorrente de DPCA. Jornal Brasiteiro Nefrologia 2002; 24:1-6.
19. Takei NL. Avaliação da colonização por Staphylococcus aureus após uso crônico de mupirocin em pacientes em diálise peritoneal ambulatorial continua [Dissertação de mestrado]. Universidade Federal de São Paulo, Brazil; 2003.
20. Ortiz A, Machuca E, Rablaghati R, Morales R, Garcia P. Peritoneal dialysis-associated peritonitis: bacteriological and clinical outcomes [Abstract]. Perit Dial Int2005; 25(Suppl 1):S10.
21. Holley JL, Bernardini J, Perlmutter JA, Piraino B. A comparison of infection rates among older and younger patients on continuous peritoneal dialysis. Perit Dial Int 1994; 14:66-9.
22. Fernandez MA, Ortiz AM, Valenzuela M, Morales RA. Peritoneal dialysis in chronic renal failure patients over 65 years of age. Adv Perit Dial 2004; 20:128-31.
23. Farias MG, Soueie JM, McClellan W, Mitch WE. Race and risk of peritonitis: an analysis of factors associated with the initial episode. Kidney Int 1994; 46:1392-6.
24. Juergensen PH, Wuerth DB, Juergensen DM, Finkelstei SH, Steele TE, Kliger AS, et al. Psychosocial factors and clinical outcome on CAPD. Adv Perit Dial 1997; 13:121-4.
25. Caramori JCT, Barretti P, Soares V. Risk factors for peritonitis in CAPD. Multivariate analysis [Abstract]. In: XVth International Congress of Nephrology, May 2-6, 1999, Buenos Aires, Argentina: ISN; 1999: 309.
26. Chow KM, Szeto CC, Leung CB, Law MC, Li PKT. Impact of social factors on patients on peritoneal dialysis. Nephrol Dial Transplant 2005; 20:2504-10.
27. Correa-Rotter R. APD in the developing world: is there a future? Semin Dial 2002; 15:385-7.
28. Locatelli AJ, Marcos GM, Gomes MG, Alvarez SA, De Benedetti LC. Comparing peritonitisin continuous ambulatory peritoneal dialysis patients versus automated peritoneal dialysis patients. Adv Perit Dial 1999; 15:193-6.
29. Locatelli A, Marcos G, Alvarez S, Gomes M, De Benedetti L, Veron D. Peritonitis rates, adequacy, and survival in continuous ambulatory (CAPD) and automated peritoneal dialysis (APD) patients [Abstract]. Perit Dial Int 2003; 23(Suppl 1):S24.
30. Bevilacqua JL, Bernardo MFOB, Camargo MC, Gomes JG. Comparação entre a incidência de peritonite de diĺise peritoneal contínua ambulatorial (DPAC) e diálise peritoneal automática (DPA). Jornal Brasileiro Nefrologia 2000; XXII:103-P275.
31. Oo TN, Roberts TL, Collins AJ. A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients. Am J Kidney Dis 2005; 45:372-80.
32. International Research Institute for Climate and Society: http://iridl.ldeo.columbia.edu/maproom/.Regional/.S_America/ .Climatologies; [accessed 5 October 2006]
33. Kim MJ, Song JH, Park YJ, Kim GA, Lee SW. The influence of seasonal factors on the incidence of peritonitis in continuous ambulatory peritoneal dialysis in the temperate zone. Adv Perit Dial 2000; 16:243-7.
34. Szeto CC, Chow KM, Wong TY, Leung CB, Li PK. Influence of climate on theincidence of peritoneal dialysis-related peritonitis. Perit Dial Int 2003; 23:580-6.
35. Alves FR, Dantas RC, Lugon JR. Higher incidence of catheter-related infectionsin a tropical climate. Adv Perit Dial 1993; 9:244-7.
36. Batalha JEN, Caramori JCT, Cioffi J, Balbi AL, Martin LC, Montelli AC, et al. Influência do índice pluviométrico e da temperatura nas peritonites de pacientes em diálise peritoneal ambulatorial [Abstract]. Jornal Brasileiro Neftologia 2002; XXIV(Suppl 2):42.
37. Viglino G, Cancarini GC, Catizone L, Cocchi R, De Vecchi A, Lupo A, et al. Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Italian Cooperative Peritoneal Dialysis Study Group. Nephrol Dial Transplant 1994; 9:1443-8.
38. D'Avila R. Peritonites em CAPD: diferenčas entre os pacientes diabéticos e não diabéticos [Abstract]. Jornal Brasileiro Nefrologia 1995; XVII(Suppl 2):27.
39. Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004; 24:424-32.
40. Veron D, De Paulis A, Santoianni J, Zucchini A, Gutierrez M, Predari SC. Peritonitisin peritoneal dialysis. Ten years experience [Abstract]. In: XVth International Congress of Nephrology, May 2-6, 1999; Buenos Aires, Argentina: ISN; 1999: 1229.
41. Concha S, Mejia OL. La influencia de Los episodios de peritonitis en un programa de dialisis peritoneal ambulatorio continua (DPAC). Acta Médica Colombiano 1995; 20:31-42.
42. Miorin LA, Gomes KS, Macedo CS, Saravia RM, Silva HGS, Sens YAS, et al. Peritonite em diálise peritoneal continua - relação com o estado de portador [Abstract]. In: XVIth Congresso Brasileiro de Nefrologia, Rio de Janeiro, Brazil; 1992: 22.
43. Menezes JAV, Rocha MA, Gončalves RV, Andrade ES, Maia AV, Mendes DGS. CAPD - 9 anos de experiência na CDR-Nova Iguaçu - RJ. Jornal Brasileiro Neftologia 1998; XX: 166-P395.
44. Breien Alcaráz HS, Rojas Lopez V, Loza Romero AE. Incidence of germs and their sensitivity: 444 cultures of peritoneal dialysis (PD) liquid [Abstract]. Perit Dial Int 2006; 26(Suppl 1):S27.
45. Pecoits-Filho RFS, Pasqual DD, Fuerbringer R, Sauthier SM, Riella MC. Diálise peritoneal contínua ambulatorial (DPCA): experiência de 15 anos em Curitiba. Jornal Brasileiro Nefrologia 1998; 20:22-30.
46. Silva MM, Pecoits-Filho R, Rocha CS, Stinghen AE, Pachaly MA, Nascimento MM, et al. The recommendations from the International Society for Peritoneal Dialysis for peritonitis treatment: a single-center historical comparison. Adv Perit Dial 2004; 20:74-7.
47. Lima RC, Barreira A, Cardoso FL, Lima MH, Leite M Jr. Ciprofloxacin and cefazolin as a combination for empirical initial therapy of peritoneal dialysis-related peritonitis: five-year follow-up. Perit Dial Int 2007; 27:56-60.
48. Lôbo JVD, Bastos KA. Peritonite em Pacientes Renais Crônicos em Programa de Diálise Peritoneal [Monografia]. Universidade Federal de Sergipe, Brazil; 2006.
49. Sesso R, Draibe S, Castelo A, Sato I, Leme I, Barbosa D, et al. Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis. Clin Nephrol 1989; 31:264-8.
50. Pignatari A, Pfaller M, Hollis R, Sesso R, Leme I, Herwaldt L. Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol 1990; 28:1898-902.
51. Amato D, Ventura MJRN, Miranda G, Leafios B, Alcántara G, Hurtado ME, et al. Staphylococcal peritonitis in continuous ambulatory peritoneal dialysis: colonization with identical strains at exit site, nose and hands. Am J Kidney Dis 2001; 37:43-8.
52. Garcia-Garcia G, Esparza S, Piña M, Tachiquin N. Microbiology of CAPD-related peritonitis in Mexico [Abstract]. Perit Dial Int 2001; 21(Suppl 2):S117.
53. Caramori JCT, Calsolari RAO, Montelli AC, Barretti P. Incidência e características microbiológicas das peritonites por staphylococcus coagulase-negativo em CAPD. Jornal Brasileiro Nefrologia 2000; XXII:102-P237.
54. Ribeiro da Cunha MLS, Montelli A, Batalha JEN, Fioravante AM, Caramori JCT, Barretti P. Predictive factors of outcome following staphylococcal peritonitis in continuous ambulatory peritoneal dialysis. Clin Nephrol 2005; 64:378-82.
55. Montelli AC, Barretti P, Batalha JEN, Cunha MLRC, Martin LC, Gabriel DP, et al. Características microbiológicas de bactérias gram negativas isoladas de pacientes com peritonites em diálise peritoneal domiciliar. Jornal Brasiteiro Neftologia 2004; 26:116-P267.
56. Szeto CC, Chow VCY, Chow KM, Lai RWM, Chung KY, Leung CB, et al. Enterobacteriaceae peritonitis complicating peritoneal dialysis: a review of 210 consecutive cases. Kidney Int 2006; 69:1245-52.
57. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein F. Differing outcomes of gram-positive and gram-negative peritonitis. Am J Kidney Dis 1998; 32:623-8.
58. Onozato ML, Caramori JCT, Barretti P. Initial treatment of CAPD peritonitis: poor response with association of cefazolin and amikacin. Perit Dial Int 1999; 19:88-9.
59. Perez Fontan M, Rodriguez-Carmona A, Garcia-Naveiro R, Rosales M, Villaverde P, Valdes F. Peritonitis-related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int 2005; 25:274-84.
60. Pru CE, Cuervo C, Ardila M. Fungal peritonitis: demographics risk factors [Abstract]. Perit Dial Int 1992; 12(Suppl 1): S151.
61. Peacock SJ, Howe PA, Day NP, Crook DW, Winearls CG, Berendt AR. Outcome following staphylococcal peritonitis. Perit Dial Int 2000; 20:215-19.
62. Vogel L, Sloos JH, Spaargaren J, Suiker I, Dijkshoorn L. Biofilm production by Staphylococcus epidermidis isolates associated with catheter related bacteremia. Diagn Microbiol Infect Dis 2000; 36:139-41.
63. Finkelstein ES, Jekel J, Troidle L, Gorban-Brennan N, Finkelstein FO, Bia FJ. Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis. Am J Kidney Dis 2002; 39:1278-86.
64. Cunha MLRS, Caramori JCT, Batalha JEN, Fioravante AM, Montelli A, Barretti P. Significance of slime as virulence factor in coagulase-negative staphylococcus peritonitis in CAPD. Perit Dial Int 2004; 24:191-3.
65. Dingues MM, Orwin PM, Schlievert M. Exotoxins of Staphylococcus aureus. Clin Microbial Rev 2000; 13:16-34.
66. Barretti P, Montelli AC, Cunha MLRS, Caramori JCT. Tratamento atual das peritonites ern diálise peritoneal ambulatorial contínua. Jornal Brasileiro Nefrologia 2001; 23:114-20.
67. Predari SC, Abalo AB, Santoianni JE, Prado A, Ribas CM, Zucchini A. Peritonitis em dialisis a peritoneal continua ambulatória: evaluacion microbiológica y clinica. Medicina (B Aires) 1990; 50:102-6.
68. Gabriel DP, Silva VS, Barsante RC, Martin LC, Caramori JCT, Balbi AL, et al. Tratamento das peritonites na evolução em diálise peritoneal: cefazolina e aminoglicosídeos X cefazolina e ceftazidima. Jornal Brasileiro Nefrologia 2004; 26:145-P380.
69. Caramori JCT, Felippe MJDB, Bartoli LD, Redondo AP, Kawano PR, Barretti P. Tratamento inicial das peritonites em CAPD, com a associação vancomicina e ofloxacina. Estudo de 121 casos [Abstract]. Jornal Brasileiro Nefrologia 1997; XIX(Suppl 4):57.
70. Garcia-Garcia G, Tachiquin-Bautista N, Luquin-Arellano VH, Ibarra-Herandez N, Aviles-Gomez R, Briseno-Renteria G, et al. Risk of peritonitis among disadvantaged CAPD patients in Mexico. Contrib Nephrol 2007; 154:145-52.